CD19 CARvac T Cells for Patients With Relapsed / Refractory B Cell Malignancies
Clinical trial NCT04156243 · UNKNOWN
Trial details
- NCT number
- NCT04156243
- Sponsor
- iCell Gene Therapeutics
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-01
- Primary completion
- 2020-02-28
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.